[Extremely undifferentiated acute erythremic myelosis].
D000135:Acid Phosphatase / Q000097:blood; D000208:Acute Disease; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001772:Blood Cell Count; D001853:Bone Marrow / Q000473:pathology; D001856:Bone Marrow Examination; D002675:Child, Preschool; D003581:Cytodiagnosis; D003937:Diagnosis, Differential; D004912:Erythrocytes / Q000201:enzymology; D004920:Erythropoiesis; D004950:Esterases / Q000097:blood; D006651:Histocytochemistry; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007202:Indicators and Reagents; D007223:Infant; D004915:Leukemia, Erythroblastic, Acute / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000201:enzymology / Q000473:pathology
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D007202:Indicators and Reagents; D004950:Esterases; D000135:Acid Phosphatase
Zur Frage der akuten, extrem unreifzelligen Erythrämie.